{
    "2021-02-17": [
        [
            {
                "time": "2021-02-04",
                "original_text": "Johnson & Johnson's COVID-19 Vaccine Inventory Is Lighter Than Expected",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "COVID-19",
                        "Vaccine",
                        "Inventory",
                        "Lighter",
                        "Expected"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-05",
                "original_text": "Coronavirus update: Biden administration increases vaccine doses to states; UK approves first human challenge trial",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "Biden",
                        "administration",
                        "increases",
                        "vaccine",
                        "doses",
                        "UK",
                        "approves",
                        "human",
                        "challenge",
                        "trial"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-06",
                "original_text": "Johnson & Johnson has only a few million COVID-19 vaccine doses in stock as likely launch nears",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "few",
                        "million",
                        "COVID-19",
                        "vaccine",
                        "doses",
                        "stock",
                        "launch",
                        "nears"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-07",
                "original_text": "COVID-19 cases are dropping like a rock: Morning Brief",
                "features": {
                    "keywords": [
                        "COVID-19",
                        "cases",
                        "dropping",
                        "rock",
                        "Morning",
                        "Brief"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-08",
                "original_text": "Johnson & Johnson has only a few million COVID vaccine doses in stock as likely launch nears",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "few",
                        "million",
                        "COVID",
                        "vaccine",
                        "doses",
                        "stock",
                        "launch",
                        "nears"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-09",
                "original_text": "3 Surefire Stocks to Buy If the Market Crashes",
                "features": {
                    "keywords": [
                        "Surefire",
                        "Stocks",
                        "Buy",
                        "Market",
                        "Crashes"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-10",
                "original_text": "Novavax Trips Despite Covid Vaccine License Deal; Is NVAX Stock A Buy?",
                "features": {
                    "keywords": [
                        "Novavax",
                        "Trips",
                        "Covid",
                        "Vaccine",
                        "License",
                        "Deal",
                        "NVAX",
                        "Stock",
                        "Buy"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-11",
                "original_text": "Like Dividends? I Bet You'll Love These 3 Stocks",
                "features": {
                    "keywords": [
                        "Dividends",
                        "Love",
                        "Stocks"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-12",
                "original_text": "UPDATE 4-'I feel blessed', says doctor as South Africa launches vaccination drive",
                "features": {
                    "keywords": [
                        "UPDATE",
                        "blessed",
                        "doctor",
                        "South",
                        "Africa",
                        "launches",
                        "vaccination",
                        "drive"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-13",
                "original_text": "Here's Why We're Wary Of Buying Johnson & Johnson's (NYSE:JNJ) For Its Upcoming Dividend",
                "features": {
                    "keywords": [
                        "Wary",
                        "Buying",
                        "Johnson & Johnson",
                        "NYSE:JNJ",
                        "Upcoming",
                        "Dividend"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}